These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25298160)

  • 41. Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.
    Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Baines SD; Wilcox MH
    J Antimicrob Chemother; 2014 Aug; 69(8):2137-47. PubMed ID: 24788662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vitro Antimicrobial Activity and Probiotic Potential of
    Monteiro CRAV; do Carmo MS; Melo BO; Alves MS; Dos Santos CI; Monteiro SG; Bomfim MRQ; Fernandes ES; Monteiro-Neto V
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30795551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model.
    Baines SD; Chilton CH; Crowther GS; Todhunter SL; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2013 Aug; 68(8):1842-9. PubMed ID: 23557928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model.
    Chilton CH; Crowther GS; Todhunter SL; Ashwin H; Longshaw CM; Karas A; Wilcox MH
    J Antimicrob Chemother; 2015 Sep; 70(9):2598-607. PubMed ID: 26078392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.
    Yan LH; Le Roux A; Boyapelly K; Lamontagne AM; Archambault MA; Picard-Jean F; Lalonde-Seguin D; St-Pierre E; Najmanovich RJ; Fortier LC; Lafontaine D; Marsault É
    Eur J Med Chem; 2018 Jan; 143():755-768. PubMed ID: 29220796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antimicrobial profile and clinical evidence of fidaxomicin (Dafclir
    Takeda S; Miki T
    Nihon Yakurigaku Zasshi; 2019; 154(4):217-229. PubMed ID: 31597902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degradation of food-derived opioid peptides by bifidobacteria.
    Sakurai T; Yamada A; Hashikura N; Odamaki T; Xiao JZ
    Benef Microbes; 2018 Jun; 9(4):675-682. PubMed ID: 29633643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory Effect of Epigallocatechin Gallate on the Virulence of Clostridium difficile PCR Ribotype 027.
    Yun B; Oh S; Song M; Hong YS; Park S; Park DJ; Griffiths MW; Oh S
    J Food Sci; 2015 Dec; 80(12):M2925-31. PubMed ID: 26556797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equol inhibits growth and spore formation of Clostridioides difficile.
    Tanaka Y; Kimura S; Ishii Y; Tateda K
    J Appl Microbiol; 2019 Sep; 127(3):932-940. PubMed ID: 31211883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro evaluation of Bifidobacterium strains of human origin for potential use in probiotic functional foods.
    Souza TC; Silva AM; Drews JR; Gomes DA; Vinderola CG; Nicoli JR
    Benef Microbes; 2013 Jun; 4(2):179-86. PubMed ID: 23443950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria.
    Cermak P; Olsovska J; Mikyska A; Dusek M; Kadleckova Z; Vanicek J; Nyc O; Sigler K; Bostikova V; Bostik P
    APMIS; 2017 Nov; 125(11):1033-1038. PubMed ID: 28960474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Outcomes of Clostridium difficile enterocolitis after administration of antibiotics along with probiotic supplement].
    Doder R; Kovacević N; Munćan D; Potkonjak A; Tomasev B; Ruzić M
    Med Pregl; 2013; 66(5-6):209-13. PubMed ID: 23888728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of biologically active scFv and VHH antibody fragments in Bifidobacterium longum.
    Shkoporov AN; Khokhlova EV; Savochkin KA; Kafarskaia LI; Efimov BA
    FEMS Microbiol Lett; 2015 Jun; 362(12):fnv083. PubMed ID: 25994292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridium difficile Biofilm.
    Vuotto C; Donelli G; Buckley A; Chilton C
    Adv Exp Med Biol; 2018; 1050():97-115. PubMed ID: 29383666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.
    Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2005 Jun; 55(6):974-82. PubMed ID: 15860551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The antimicrobial action of low-molar-mass chitosan, chitosan derivatives and chitooligosaccharides on bifidobacteria.
    Simůnek J; Koppová I; Filip L; Tishchenko G; Bełzecki G
    Folia Microbiol (Praha); 2010 Jul; 55(4):379-82. PubMed ID: 20680576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline.
    Shen AY; Chen CP; Roffler S
    Life Sci; 1999; 64(9):813-25. PubMed ID: 10075114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of mupirocin-based media for selective enumeration of bifidobacteria in probiotic supplements.
    Bunesova V; Musilova S; Geigerova M; Pechar R; Rada V
    J Microbiol Methods; 2015 Feb; 109():106-9. PubMed ID: 25542994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro.
    Trejo FM; Pérez PF; De Antoni GL
    Antonie Van Leeuwenhoek; 2010 Jun; 98(1):19-29. PubMed ID: 20232250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.